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BACKGROUND: We aim to determine if C-reactive protein (CRP), lipopolysaccharide-binding pro-
tein (LBP), and procalcitonin (PCT) in drain fluid can serve as screening tools for colorectal anasto-
motic leakage (CAL).
METHODS: Patients included in this multicenter prospective observational study underwent left
hemicolectomy, sigmoid resection, high anterior resection, low anterior resection, or subtotal colect-
omy. During the first 5 postoperative days, CRP, LBP, and PCT were determined on drain fluid.
RESULTS: In total 243 patients were included, of whom 19 (8%) developed CAL. CRP levels were
higher in patients with leakage on day 3 and day 5, levels of LBP were higher on days 2, 3, and 4, and
PCT levels were higher on day 5. Multivariate analysis showed LBP to be significantly related to CAL.
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er chance of CAL and could contribute in a future prognostic model for CAL.
 2014 Elsevier Inc. All rights reserved.Despite the vast body of evidence, colorectal anasto-
motic leakage (CAL) remains a poorly understood compli-
cation of colorectal surgery. The reported incidence of CAL
is estimated between 2.4% and 19%,1–3 and mortality rates
because of sepsis and multiorgan failure are around 15%.4
With current screening and diagnostic methods, the interval
between construction of the colorectal anastomosis and
diagnosis of leakage varies between 6 and 13 days.5–7
Several studies have suggested that delay of diagnosis of
CAL is associated with higher mortality rates and that
only early management improves clinical outcome.8–10
Therefore, new screening methods allowing detection of
CAL in the early postoperative phase are needed. A
biomarker reflecting the local inflammation, ie around the
anastomosis, could be an objective screening tool for
CAL in an early phase.
C-reactive protein (CRP) is an acute-phase protein
displaying rapid and pronounced rise of its serum concen-
tration in response to infection or inflammation. It is mainly
produced by hepatocytes; however, Kupffer cells, blood
monocytes, and alveolar macrophages have been shown to
produce CRP as well.11
Lipopolysaccharide-binding protein (LBP) is a glycopro-
tein produced mainly in the liver, but is also produced in the
skin, lung, intestine, and at local sites of injury and infection.
Particularly LBP produced at local sites of infection is
considered to contribute to bacterial clearing.12
Procalcitonin (PCT) is a potential marker of acute inflam-
mation that is released from different parenchymal tissues and
differentiated cell types throughout the body, mostly from the
liver and adipose tissue, in response to interleukin levels
increased in case of bacterial infections.13–16
The aim of this study is to determine if CRP, LBP, and
PCT in drain fluid can serve as noninvasive screening tools
for CAL in the early postoperative phase after colorectal
surgery.Methods
Patients included in the Analysis of Parameters Predictive
of Evident Anastomotic Leakage (APPEAL) study received
left-sided colorectal resection with the construction of an
anastomosis and were given an intra-abdominal drain. Seven
medical centers in The Netherlands and Belgium participated
in this study. The study, registered in the Dutch Trial Register
(http://www.trialregister.nl, study number NTR 1258), was
approved by the medical ethical committee of all the partici-
pating centers, in accordance with the ethical standards of the
Helsinki Declaration of 1975, and all patients gave informed
consent. Participating centers included patients consecu-
tively between January 2007 and December 2009.Inclusion and exclusion criteria
Patients undergoing left hemicolectomy, sigmoid resec-
tion, high anterior resection (with partial mesorectal
excision), low anterior resection (with total mesorectal
excision), and subtotal colectomy with ileorectal anasto-
mosis were included. Oncologic resections as well as
resections for benign diseases were included. Emergency
operations were excluded because of the high probability of
coexisting tissue damage and logistical difficulties. Re-
versals of colostomy were also excluded since the primary
disease was already treated. Furthermore, patients under
18 years of age, patients who refused to participate, and
patients who did not receive a drain were excluded.
Surgical procedure
The surgical procedure was left to the surgeon’s discre-
tion. All patients received preoperative antibiotic prophy-
laxis and an intra-abdominal drain. Guidelines concerning
bowel preparation in the participating centers were re-
spected. Patients were operated by laparotomy or laparos-
copy and the anastomosis was stapled or hand-sutured. A
diverting stoma was constructed according to the surgeon’s
preference. To obtain drain fluid, a drain was placed at the
anastomotic site and was left in place during the first 5
postoperative days. The type of drain used was left to the
surgeon’s discretion.
Determination of C-reactive protein,
lipopolysaccharide-binding protein, and
procalcitonin
Drain fluid reservoirs were emptied 2 times a day with
12-hour intervals, respecting the rules of sterility. The
evening collection was disposed of. The morning collection
was centrifuged for 10 min at 2,800g and 4C. The super-
natant was brought into different cryotubes that were frozen
at 280C to allow analysis in batch.
LBP was determined by a 2-sited chemiluminescent
immunometric enzyme assay (IMMULITE 1000, Siemens,
Los Angeles, CA). For CRP determination, the Tina-quant
assay on the Hitachi 912 (Roche Diagnostics, Penzberg,
Germany) was used. PCT was determined with an immu-
noluminometric assay (LUMI-test PCT, BRAHMS Diag-
nostika, Berlin, Germany).
Definitions
The endpoint of the APPEAL study was symptomatic
CAL. This was defined as a clinically manifest
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requiring intervention, confirmed by radiological studies,
reoperation, or fecal discharge from the drain. Radiologic
confirmation of CAL was defined as extravasation of
endoluminally administrated water-soluble contrast and/or
significant perianastomotic air on computed tomography or
X-ray. Radiological studies were not routinely performed,
only in case of clinical suspicion of CAL. Interventions to
treat CAL consisted of therapeutic drainage (prolonged stay
of drain), use of therapeutic antibiotics, or a surgical
intervention, ie construction of a diverting stoma, discon-
nection of the anastomosis, and construction of a new
anastomosis or a colostomy. All postoperative fistulas
communicating with the surgical anastomosis were classi-
fied as a leak. Postoperative abscesses were classified as
anastomotic leakage if there was extravasation of enteric
contrast on radiological studies, if there was significant
perianastomotic air, or if communication with the anasto-
mosis was noted after radiologic drainage. Postoperative
mortality was defined as patients who died within 30 days
of operation, in hospital and after discharge.
Data collection
Patients were followed from their preoperative admission
on the ward until the first postoperative follow-up at the
outpatient clinic. Demographic data of the patients, operative
details, postoperative events, and follow-up data were
obtained through a standardized case record form and entered
into a database. In case of CAL, the postoperative day of
diagnosiswas noted alongwith themanifestation ofCAL, the
diagnostic tool for detection of the leak, and the treatment.
Statistics
Categorical data are presented as numbers with percent-
ages, numerical data are presented as means 6 standard
deviation of the mean (normally distributed), or medians with
interquartile ranges (not normally distributed). Univariate
analysis was performed using a chi-square test in case of
categorical data and an unpaired t test or one-way analysis of
variance (normallydistributed) andMann–WhitneyU test (not
normally distributed) in case of numerical data. To determine
whether the individualCRP,PCT, andLBPfluctuations in time
were related to the risk of CAL, we fitted mixed effects model
with random cubic splines for the normalized responses of
CRP, LBP, and PCT to account for nonlinear character of the
responses. Each model contained the following fixed effects:
age, American Society of Anesthesiologists classification,
sex, approach (laparoscopic or open), use of corticosteroids,
time effects of the order up to 3 or less (depending on the
response), and the interaction terms between time effects
and factors American Society of Anesthesiologists classifica-
tion, sex, approach (laparoscopic or open), and use of cortico-
steroids. Each model contained as random effects a random
intercept and random effects of time.From each univariate model random effects were esti-
mated using empirical Bayes estimates and plugged into the
logistic model for CAL and the survival model for time to
CAL. To correct for uncertainty of the plug-in covariates, we
sampled random effects from the fitted polynomial mixed
regression models and fitted the logistic/survival models for
each sample. As the final estimate, we took an average of the
obtained estimates. Final standard errors were calculated
taking into account within and between samples variability.Results
A total of 243 patients were included. The mean age was
64 6 12 years; 135 patients (56%) were men and 108
(44%) were women. Thirty-three patients (14%) were
treated for inflammatory diseases, 206 patients (84%)
were treated for malignancy, and 4 patients (2%) had
ischemic colitis. Fifty-six patients (23%) underwent pre-
operative radiotherapy, and in 59 patients (25%) a defunc-
tioning stoma was constructed. A total of 92 (38%) patients
underwent a laparoscopic procedure and 151 patients
(62%) were operated through laparotomy.
Nineteen patients (8%) developed clinical CAL. In 9
patients it became manifest as sepsis, in 7 patients as
peritonitis, 2 patients developed a presacral abscess, and 1
patient developed an intra-abdominal abscess. In 8 patients
the diagnosis was made by computed tomography, in 7
patients by relaparotomy, and in 4 patients fecal discharge
from the drain occurred. Median interval between operation
and confirmation of CAL was 6 days (range 2 to 26 days).
Two patients (.8%) developed an infection at the drain
insertion site, both in the group without CAL. Average
hospital stay of patients with CAL was significantly longer
(286 22 days vs 13 6 13 days; P , .0001). In the group of
patients with CAL 3 died (16%), whereas 6 patients (3%)
died in the group without CAL (P 5 .002).
Table 1 shows the baseline characteristics of the patients
with CAL compared to the patients without CAL. The inci-
dence of pulmonary comorbidity and the number of pa-
tients using corticosteroids were significantly higher in
the leakage group.
Drain fluid production was compared between the
groups with and without leakage. No significant difference
between the 2 groups was found.
Univariate analysis shows that CRP levels are signifi-
cantly higher in patients with leakage on day 3 and day 5
postoperatively (Fig. 1). Levels of LBP are significantly
higher in patients with leakage on days 2, 3, and 4 after
the operation (Fig. 2). The PCT concentration is signifi-
cantly higher on day 5 in case of leakage (Fig. 3). In the
multivariate analysis for LBP, we found a significant effect
of the random intercept after correcting by sampling
method (Table 2). This suggests that the higher the initial
value of LBP the higher the risk of leakage. Both LBP
and the random effects were normalized. Therefore, this
means that an increase in the average initial value of LBP
Table 1 Univariate analysis of baseline characteristics of the total APPEAL population: patients without CAL versus the patients with
CAL
Variable No CAL (n 5 224) CAL (n 5 19) P value
Age (y) 64 6 12 65 6 13 .765
Sex
Male 125 (93%) 10 (7%) .789
Female 99 (92%) 9 (8%)
BMI (kg/m2)
,25 80 (91%) 9 (9%) .155
25–30 109 (98%) 5 (2%)
.30 35 (88%) 5 (12%)
Smoking
Yes 50 (94%) 3 (6%) .750
No 168 (92%) 15 (8%)
Steroids
Yes (chronic) 2 (40%) 3 (60.0%) .000
Yes (perioperatively) 16 (80%) 4 (20%)
No 205 (94%) 12 (6%)
ASA score
1–2 173 (93%) 13 (7%) .532
3–4 50 (89%) 6 (11%)
Neoadjuvant radiotherapy
Yes 51 (91%) 5 (9%) .945
No 173 (93%) 14 (7%)
Type of resection
TME/LAR 76 (92%) 7 (8%) .727
PME/HAR 55 (95%) 3 (5%)
Left hemicolectomy 21 (96%) 1 (4%)
Sigmoid resection 68 (90%) 8 (10%)
Subtotal colectomy 4 (100%) 0 (0%)
Height anastomosis (cm)
.7 149 (94%) 10 (6%) .211
,7 74 (89%) 9 (11%)
Construction anastomosis
Stapled 178 (93%) 14 (7%) .735
Handsewn 45 (90%) 5 (10%)
Configuration anastomosis
End-to-end 57 (86%) 9 (14%) .259
End-to-side 16 (94%) 1 (6%)
Side-to-end 122 (94%) 8 (6%)
Side-to-side 23 (96%) 1 (4%)
Protective ileostomy
Yes 55 (93%) 4 (7%) .933
No 167 (92%) 15 (8%)
ASA 5 American Society of Anesthesiologists; CAL 5 colorectal anastomotic leakage; HAR 5 high anterior resection; LAR 5 low anterior resection;
PME 5 partial mesorectal excision; TME 5 total mesorectal excision.
320 The American Journal of Surgery, Vol 208, No 3, September 2014at the first postoperative day with 1 standard deviation in-
creases the risk of leakage by exp(.5) 5 1.6 times. In addi-
tion, we found the use of steroids to be independently
associated with CAL as well. No significant results were
obtained in the multivariate analysis of PCT and CRP.
Univariate analysis of the acute phase protein (APP) data
on each postoperative day was also performed with outcome
variables other than CAL. Comparison of means between
patients undergoing laparoscopic versus open surgery re-
sulted in significantly higher concentrations in the open
surgery group of CRP on day 1 (P 5 .014) and 2 (P 5 .018)
and of PCT on day 2 (P 5 .026). No significantly differentconcentrations for LBP were found. Similar analysis
comparing patients with a diverting stoma to patients
without a stoma showed no significant results for neither
of the 3 analyzed APPs (P . .120). Indication for operation
(malignancy, inflammatory, and other) as outcome variable
also did not reveal significant results (P . .087).Comments
APPs are produced in the liver, extrahepatically and at
the site of injury in case of LBP. Therefore levels at the
Figure 1 Differences in CRP concentrations (mg/L) between
patients with and without CAL. *Postoperative day on which dif-
ferences are significant (day 3, P 5 .003; day 5, P 5 .013).
N. Komen et al. Acute phase proteins in drain fluid 321local milieu could be a more specific indicator for local
infection, like CAL.
CRP plays a role in recognizing pathogens and activating
the complement system and phagocytic cells. Furthermore, it
contributes to restoration of normal structure and function of
injured tissues.17 CRP in plasma has been used for a long time
to objectify disease activity in infective or noninfective inflam-
matory states.18 For CRP in drain fluid, univariate analysis
shows a significant difference between patients with CAL
and patients without CAL on days 3 and 5 postoperatively.
Multivariate analysis renders no significant results. The differ-
ences between laparoscopic versus open surgery may be ex-
plained by the greater tissue damage resulting from open
surgery, leading to a greater inflammatory reaction.
LBP enhances the inflammatory response to gram-
negative bacteria by transferring LPS (Lipopolysaccharide)
to a host membrane protein (m)CD14, causing the release
of proinflammatory cytokines that recruit neutrophils as an
early, innate immune response.19 High serum LBP levels
have been shown to correlate with the onset of bacteremia
and sepsis.20 Since gram-negative bacteria are abundantly
present in the colon, significantly higher LBP concentra-
tions in patients with CAL on days 2, 3, and 4 postopera-
tively could be expected. Moreover, multivariate analysisFigure 2 Differences in LBP concentrations (mg/mL) between
patients with and without CAL. *Postoperative day on which dif-
ferences are significant (day 2, P 5 .040; day 3, P 5 .039; day 4,
P 5 .003).has shown that an increase of LBP levels in drain fluids
is associated with a significantly higher risk for CAL.
In a nonseptic condition, PCT is produced primarily in
neuroendocrine C cells of the thyroid.15 However, bacterial
infection has been shown to induce a release of PCT from
different parenchymal tissues and differentiated cell types
throughout the body. The serum level of PCT has been sug-
gested to be a sensitive indicator of ongoing abdominal
sepsis and could help in deciding whether to perform a re-
laparotomy.21 In drain fluid, a significant difference be-
tween patients with CAL and patients without CAL was
found only on day 5 postoperatively. However, multivariate
analysis renders no significant results. Levels of PCT were
significantly higher in the open surgery group on day 2.
Perhaps this could be because of a larger intraoperative
spill in the open group. However, on day 1 the difference
is not significant contradicting this hypothesis.
This is the first study concerning acute phase proteins in
drain fluid and was conducted to study if APPs have
diagnostic value when determined in the perianastomotic
environment. Several studies in search of a biomarker for
CAL in drain fluid have been performed. The majority of
studies concerns cytokines like interleukin-1b and tumor
necrosis factor-a.22 Unfortunately, no thresholds could be
defined because of the great variability in results, rendering
these parameters as not yet suited for clinical use.23 The
same problem is encountered with LBP and, in analogy
to cytokine data, consequently one can only conclude that
a correlation exists between LBP levels in drain fluid and
CAL. Probably a combination of biomarkers allows for a
more specific screening of CAL and further studies should
aim to find such a biomarker profile.
The number of samples used for each analysis does not
add up to the number of included patients. This is because
of variable and insufficient production of drain fluid in most
cases. Peritoneal lavage could be a solution; however, this
may interfere with the concentrations of the APPs. Few
samples are missing because of the accidental removal of
the drain by the patient, early intervention for CAL, and
accidental loss of drain fluid either at the ward or at the
processing laboratory.
Corticosteroids are known to impair wound healing,
however, their influence on the healing of colorectal
anastomoses is unclear and studies have reported conflict-
ing results.24–26 This study shows the use of corticosteroids
to be correlated to CAL. It confirms the results published
by Slieker et al, who used the same database.27
To date, the use of prophylactic drainage remains
controversial. Several level 1 studies have shown that
prophylactic drainage does not have a beneficial or a
detrimental effect on the incidence of CAL and on the
morbidity afterwards.28–30 A prospective study concerning
pelvic anastomosis showed a higher leakage rate after
routine irrigation–suction drainage in elective anterior
resection.31 A retrospective study showed drainage and
the use of a defunctioning stoma to be beneficial in terms
of reoperation rates as a result of anastomotic leakage after
Figure 3 Differences in PCT concentrations (ng/mL) between
patients with and without CAL. *Postoperative day on which dif-
ferences are significant (day 5, P 5 .013).
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rounding the necessity to drain, prophylactic drainage re-
mains a common practice in many hospitals, particularly
after rectal surgery.33 In addition, the outcome measures
used in these studies consist of leakage rates, hospital
stay, radiological anastomotic leakage, infectious complica-
tions, and patient comfort. In this study, we have shown
diagnostic potential of the drain. Therefore, considering
the low complication rate of prophylactic drainage, it
should be placed routinely during surgery to allow collec-
tion of drain fluid in the early postoperative period.
The statisticalmethods used in this article allow analysis of
longitudinal data on an individual level, ie analysis of
individual profiles of the acute phase proteins. We found that
an increase in LBP levels with 1 standard deviation leads to a
1.6 times increased risk of CAL in the individual patient. This
means that LBP and CAL are related. However, since it is not
possible to calculate a standarddeviationononemeasurement,
this finding by itself cannot be used in clinical practice. In
addition, because of the vast variability of the obtained values
between patients and between samples of the samepatient, it is
not possible to define general cutoff values. A personalized,
‘‘tailor made’’ approach is mandatory. In analogy with
cardiovascular research concerning risk scores (Framingham
score), a more personalized approach can be achieved by the
development of a prognostic model, determining whether
repeated measurements of a specific biomarker, in this study
LBP can ultimately provide a better understanding of diseaseTable 2 Final logistic regression model for CAL after correcting for
Coefficient log HR
Intercept 22.63
B.s [,3] .30
int.s LBP .50
Use of steroids at home (Yes vs No) 4.14
Use of steroids intraoperatively (Yes vs No) 1.56
Approach (Open vs Laparoscopy) 2.83
The intercept estimate reflects the reference value of the log hazard ratio
B.s [,3] 5 b-spline basis function of order 3; HR 5 hazard ratio; Int.s LBPprogression. The most common are dynamic predictions of
survival probabilities using the recorded longitudinal infor-
mation, namely, landmarking34 and jointmodeling.35Because
the subject-specific longitudinal trajectories can be quite com-
plex (eg nonlinear, plateaus), different features of these trajec-
tories may be more predictive for the event of interest. In our
study, we do not encounter strictly joint-modeling setting,
meaning that the recorded longitudinal information influences
the survival submodel but not the other way around. Therefore
using the 2-stage model is sufficient. Based on that model we
can perform a dynamic prediction of the patient-specific haz-
ard for a new patient by updating the patient-specific random
effect related to LBP intercept as more longitudinal data for
this patient are available. For this purpose, we can apply the
similar procedure as in the typical joint modeling situation
by using Metropolis–Hastings sampling.36 To simplify mat-
ters, a statistical black box should be visualized that allows
calculation of the chance of CAL after putting in a diagnostic
factor like the concentration of LBP on postoperative days 1
and 3 for example. Other postoperative signs and symptoms
like fever, serum CRP, and white blood cell count could be
factored in as well.
Conclusion
Increased concentrations of LBP in drain fluid are
significantly associated to a higher chance of CAL and
could contribute in a future prognostic model for CAL.
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